Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001209191-23-007314

Options or other derivatives

  • Chief Executive Officer acquired 1,600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stevens Raymond C Chief Executive Officer 2023-02-02 Grant or award · Stock option (right to buy) +1,600,000 1,600,000 D
Loading xslF345X03/doc4.xml…